Hi Renee,
Thanks for your question! Could you re-post it to the following group and see if any of the professionals might have an answer/suggestions/recommendations:
https://community.corporatecompliance.org/communities/community-home?CommunityKey=4e43a44d-a01e-4538-84bc-33dd0e72df8cThanks!
------------------------------
Stephen (Steve) Pavlicek | Community Engagement Manager
Society of Corporate Compliance and Ethics
Health Care Compliance Association
Office: 952.567.6219 | Mobile: 612.207.3172
6462 City West Parkway | Eden Prairie, MN 55344
------------------------------
Original Message:
Sent: 08-10-2022 01:28 PM
From: Renee Bullard
Subject: 340B regulations
My organization purchases OP drugs under the 340B program. In light of the recent Supreme Court ruling and the Interim OPPS rules regarding cuts CMS made to 340B drug reimbursement in 2018 to present, has any organization out there elected to now remove the JG modifier pending the final OPPS rules?
------------------------------
Renee Bullard
Compliance Ofcr/Risk Mgr
Magnolia Regional Hlth Ctr
Corinth,MS
------------------------------